Zeposia
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.zeposia.comRevenue
$7.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Zeposia
ZEPOSIA is a prescription medication designed to treat relapsing forms of multiple sclerosis (MS) and moderately to severely active ulcerative colitis (UC) in adults. The medication is taken orally once a day and is intended for patients who meet specific medical criteria. ZEPOSIA's target clients are adults suffering from these conditions, while its safety and effectiveness in children remain unknown. The company provides information on potential eligibility for co-pay savings offers for those with commercial insurance.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zeposia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Zeposia has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Zeposia had a recent Job posting/layoffs
Zeposia, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Zeposia launches new products
Earning: See what the market has to say on Zeposia recently announced quarterly report
Funding: Get notified immidiatlly once Zeposia has new funding data
Check out if Zeposia is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Zeposia
Recommended Actions
Reach out to Masked Content who joined Zeposia as Masked Content
Find more new buyers
Compare Similar Companies to Zeposia
Compare insights from companies similar to Zeposia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Zeposia
$7.2M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Zeposia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Zeposia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zeposia.
Zeposia Tech Stack
A closer look at the technologies used by Zeposia
See more technologies
Zeposia News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zeposia
Sign Up For FreeTo access detailed company insights
ZEPOSIA is a prescription medication designed to treat relapsing forms of multiple sclerosis (MS) and moderately to severely active ulcerative colitis (UC) in adults. The medication is taken orally once a day and is intended for patients who meet specific medical criteria. ZEPOSIA's target clients are adults suffering from these conditions, while i... Read More
